Alpine Woods Capital Investors LLC Has $3.57 Million Stake in Amdocs Limited (NASDAQ:DOX)

Alpine Woods Capital Investors LLC reduced its position in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 31.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,968 shares of the technology company's stock after selling 17,898 shares during the period. Alpine Woods Capital Investors LLC's holdings in Amdocs were worth $3,566,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Alyeska Investment Group L.P. increased its position in Amdocs by 86.8% during the 4th quarter. Alyeska Investment Group L.P. now owns 1,681,074 shares of the technology company's stock worth $143,127,000 after purchasing an additional 781,061 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Amdocs by 25.4% during the fourth quarter. Wellington Management Group LLP now owns 2,680,422 shares of the technology company's stock worth $228,211,000 after buying an additional 543,490 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Amdocs during the 4th quarter valued at $44,494,000. Vanguard Group Inc. grew its position in Amdocs by 16.1% during the 4th quarter. Vanguard Group Inc. now owns 3,074,424 shares of the technology company's stock worth $261,756,000 after acquiring an additional 426,035 shares during the last quarter. Finally, The Manufacturers Life Insurance Company increased its holdings in Amdocs by 2,489.0% in the 4th quarter. The Manufacturers Life Insurance Company now owns 376,383 shares of the technology company's stock worth $32,045,000 after purchasing an additional 361,845 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.

Amdocs Trading Down 1.1%

NASDAQ DOX traded down $0.98 during mid-day trading on Friday, reaching $88.26. 965,017 shares of the stock were exchanged, compared to its average volume of 664,172. The stock has a market cap of $9.96 billion, a P/E ratio of 18.58, a P/E/G ratio of 1.46 and a beta of 0.52. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.16 and a quick ratio of 1.16. Amdocs Limited has a one year low of $78.61 and a one year high of $95.41. The stock has a 50 day simple moving average of $91.63 and a 200-day simple moving average of $88.34.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The technology company reported $1.78 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.07. The firm had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.12 billion. Amdocs had a return on equity of 19.52% and a net margin of 11.39%. The business's revenue was down 9.4% compared to the same quarter last year. During the same period last year, the business posted $1.56 EPS. On average, analysts anticipate that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Monday, June 30th will be issued a dividend of $0.527 per share. The ex-dividend date is Monday, June 30th. This represents a $2.11 annualized dividend and a dividend yield of 2.39%. Amdocs's dividend payout ratio is currently 44.42%.

Analyst Upgrades and Downgrades

DOX has been the topic of a number of recent research reports. Wolfe Research began coverage on Amdocs in a research note on Tuesday, July 8th. They set an "outperform" rating on the stock. Wall Street Zen upgraded shares of Amdocs from a "hold" rating to a "buy" rating in a report on Saturday, June 7th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, Amdocs presently has an average rating of "Buy" and an average price target of $105.33.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.